Abstract
Osteopontin (OPN), also known as 44kDa bone phosphoprotein, sialoprotein I, secreted phosphoprotein I, 2ar, uropontin, and early T-lymphocyte activation-1 (Eta-1), is a multifunctional protein. OPN has been found to be expressed in various cell types and species with many physiologic and pathologic functions. OPN has emerged as a potential biomarker and mediator in cardiovascular disease. In this review, we will discuss the roles of OPN in cardiovascular disease, specifically in vascular and valvular heart disease, myocardial infarction and heart failure.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 125-131 |
| Number of pages | 7 |
| Journal | Cardiology in review |
| Volume | 18 |
| Issue number | 3 |
| DOIs | |
| State | Published - May 1 2010 |
Keywords
- Calcification
- Heart failure
- Myocardial infarction
- Myocardial remodeling
- Osteopontin
- Valvular disease
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Fingerprint
Dive into the research topics of 'Osteopontin in cardiovascular disease: A potential therapeutic target'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS